Sera Prognostics, Inc. (SERA)
2.18
+0.04
(+1.87%)
USD |
NASDAQ |
Aug 24, 16:00
2.15
-0.03
(-1.38%)
After-Hours: 20:00
Sera Prognostics Total Liabilities (Quarterly) : 27.36M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 27.36M |
| March 31, 2026 | 25.92M |
| December 31, 2025 | 27.14M |
| September 30, 2025 | 25.94M |
| June 30, 2025 | 23.60M |
| March 31, 2025 | 23.40M |
| December 31, 2024 | 24.95M |
| September 30, 2024 | 24.35M |
| June 30, 2024 | 25.11M |
| March 31, 2024 | 25.14M |
| December 31, 2023 | 25.28M |
| September 30, 2023 | 14.65M |
| Date | Value |
|---|---|
| June 30, 2023 | 15.54M |
| March 31, 2023 | 15.40M |
| December 31, 2022 | 17.39M |
| September 30, 2022 | 9.402M |
| June 30, 2022 | 8.151M |
| March 31, 2022 | 7.662M |
| December 31, 2021 | 8.465M |
| September 30, 2021 | 3.651M |
| June 30, 2021 | 230.86M |
| March 31, 2021 | 193.13M |
| December 31, 2020 | 140.37M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Myriad Genetics, Inc. | 335.00M |
| BioRestorative Therapies, Inc. | 1.615M |
| CareDx, Inc. | 107.39M |
| Natera, Inc. | 836.00M |
| Exagen, Inc. | 39.72M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 86.74M |
| Shareholders Equity (Quarterly) | 59.38M |
| Debt to Equity Ratio | 0.0505 |
| Current Ratio | 1.976 |
| Net Debt Paydown Yield | -0.68% |